The CarboMedics supra-annular Top Hat valve improves long-term left ventricular mass regression Victor X. Mosquera, MD, PhD, Alberto Bouzas-Mosquera, MD, PhD, Victor Bautista-Hernandez, MD, PhD, Francisco Estévez-Cid, MD, José M. Herrera-Noreña, MD, PhD, Nemesio Alvarez-García, MD, PhD, José J. Cuenca-Castillo, MD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 6, Pages 2845-2853.e1 (December 2014) DOI: 10.1016/j.jtcvs.2014.06.082 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Box plot depicting the left ventricular mass preoperatively and at 5 years of follow-up in both groups. LV, Left ventricular. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2845-2853.e1DOI: (10.1016/j.jtcvs.2014.06.082) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 A, Overall freedom from mortality and freedom from mortality according to valve type. B, Freedom from mortality in patients with severe myocardial hypertrophy according to valve type. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2845-2853.e1DOI: (10.1016/j.jtcvs.2014.06.082) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 3 A, Freedom thromboembolic events according to valve type. B, Freedom from endocarditis according to valve type. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2845-2853.e1DOI: (10.1016/j.jtcvs.2014.06.082) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 4 Freedom from aortic-related events, including paravalvular leaks and reoperation, according to valve type. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2845-2853.e1DOI: (10.1016/j.jtcvs.2014.06.082) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions